(Q34099110)

31 July 2017

title

Antiviral activity of NMSO3 against adenovirus in vitro (English)

1 reference

31 July 2017

1 reference

Kaneko H

1 reference

31 July 2017

Kato K

series ordinal

1 reference

31 July 2017

Mori S

series ordinal

1 reference

31 July 2017

Shigeta S

series ordinal

1 reference

31 July 2017

publication date

1 December 2001

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

281-288

1 reference

Adenovirus type 37 uses sialic acid as a cellular receptor

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Evaluation of Cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Epidemiology of epidemic keratoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Stepwise dismantling of adenovirus 2 during entry into cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

The role of the nuclear pore complex in adenovirus DNA entry

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

BIOCHEMICAL STUDIES ON ADENOVIRUS MULTIPLICATION, VI. PROPERTIES OF HIGHLY PURIFIED TUMORIGENIC HUMAN ADENOVIRUSES AND THEIR DNA's

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Adenoviruses in the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Application of a gastric cancer cell line (MKN-28) for anti-adenovirus screening using the MTT method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Evaluation of the efficacy of 2',3'-dideoxycytidine against adenovirus infection in a mouse pneumonia model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Inhibitory activity of 3'-fluoro-2' deoxythymidine and related nucleoside analogues against adenoviruses in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Recent progress in antiviral chemotherapy for respiratory syncytial virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Molecular composition of the adenovirus type 2 virion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Genetic variability of adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

Adenovirus pneumonia with severe sequelae in an immunocompetent adult

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2801%2900167-X

7 January 2021

10.1016/S0166-3542(01)00167-X

Identifiers

DOI

1 reference

31 July 2017

1 reference